Philip Helliwell

30.6k citations
454 papers · 22.9k · 11 hit papers · h-index 70

Impact in

  • Rheumatology top 0.01%
    • Spondyloarthritis Studies and Treatments
    • Rheumatoid Arthritis Research and Therapies
    • Hypertrophic osteoarthropathy and related conditions
  • Immunology top 1%
    • Psoriasis: Treatment and Pathogenesis

Papers in

Philip Helliwell

434 papers receiving 22.0k citations

Philip Helliwell's Hit Papers

GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets 2025 · 45 citations
450+6+13Years since publication50010001.5k2.0k2.5k

Peers

Philip Helliwell
Comparison fields: 5 of 116
  • Rheumatology 16.3k
  • Immunology 1.4k
  • Orthopedics and Sports Medicine 173
  • Pharmacology 241
  • Nephrology 137
Replace Jürgen Braun with:
Jürgen Braun Germany
Vivian P. Bykerk United States
Mikkel Østergaard Denmark
Harvinder S. Luthra United States
Walter P. Maksymowych Canada
Xenofon Baraliakos Germany
Emilio Martín-Mola Spain
J. M. W. Hazes Netherlands
Ingemar F. Petersson Sweden
A. Zink Germany
Philip Helliwell relative to Jürgen Braun Germany Jürgen Braun's profile →
Citations per field
00.5×1.5×
Jürgen Braun · 1×
Citations per year

Countries citing papers authored by Philip Helliwell

Since Specialization
Citations

This map shows the geographic impact of Philip Helliwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Helliwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Helliwell more than expected).

Fields of papers citing papers by Philip Helliwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Helliwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Helliwell. The network helps show where Philip Helliwell may publish in the future.

Co-authors

The 25 scholars most cited alongside Philip Helliwell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip Helliwell Line = papers co-authored together Philip Helliwell links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 454 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Classification criteria for psoriatic arthritis: Development of new criteria from a large international study
Hit paper breakdown →
20062981
2
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis
Hit paper breakdown →
2016743
3
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
Hit paper breakdown →
2016727
4
Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment
Hit paper breakdown →
2009564
5
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
Hit paper breakdown →
2017533
6 2002497
7 2008459
8
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
Hit paper breakdown →
2022426
9
Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial
Hit paper breakdown →
2015393
10 2008375
11 2011371
12
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
Hit paper breakdown →
2013358
13
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative
Hit paper breakdown →
2014331
14
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
Hit paper breakdown →
2020266
15 2012260
16 2017253
17 2008246
18 2019238
19
Consensus on a core set of domains for psoriatic arthritis.
2007235
20 2005222

About Philip Helliwell

Philip Helliwell is a scholar working on Rheumatology, Orthopedics and Sports Medicine, Immunology, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism, having authored 454 papers that have together received 22.9k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (300 papers), Rheumatoid Arthritis Research and Therapies (17 papers), Psoriasis: Treatment and Pathogenesis (8 papers), Osteomyelitis and Bone Disorders Research (7 papers), Lower Extremity Biomechanics and Pathologies (7 papers), Diabetic Foot Ulcer Assessment and Management (5 papers), Foot and Ankle Surgery (4 papers) and Ergonomics and Musculoskeletal Disorders (4 papers). The work is most often cited by research in Rheumatology (16.3k citations), Immunology (1.4k citations), Orthopedics and Sports Medicine (173 citations), Pharmacology (241 citations) and Nephrology (137 citations). Philip Helliwell has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Laura C. Coates, Philip J. Mease, Dafna D. Gladman, William John Taylor, Antonio Marchesoni, Herman Mielants, Paul J. Healy, Robin Waxman, James Albert Woodburn and Paul E. Emery. Their work appears in journals such as The Journal of Rheumatology, Lara D. Veeken, Annals of the Rheumatic Diseases, Arthritis Care & Research and Clinical Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact